Rutgers Cancer Institute of NJ /ID# 1140-0803 is a clinical research site located in New Brunswick, New Jersey, United States 08903.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Rutgers Cancer Institute of NJ /ID# 1140-0803 has participated in 1 clinical trials.
Therapeutic areas: Chronic Graft Versus Host Disease.
Sponsors: Pharmacyclics LLC..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New Jersey · View every site in New Brunswick
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rutgers Cancer Institute of NJ /ID# 1140-0803 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rutgers Cancer Institute of NJ /ID# 1140-0803 has 1 clinical trials on record. Their work covers Chronic Graft Versus Host Disease.
Rutgers Cancer Institute of NJ /ID# 1140-0803 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.